Navigation Links
The trouble with hybrids
Date:2/7/2008

Hybrid electric vehicles that run on both conventional gasoline and stored electricity can be no more than a stop gap until more sustainable technology is developed, according to researchers in France. Writing in the Inderscience publication International Journal of Automotive Technology and Management, they suggest that the adoption of HEVs might even slow development of more sustainable fuel-cell powered electric vehicles.

Jean-Jacques Chanaron Research Director within the French National Centre for Scientific Research (CNRS) and Chief Scientific Advisor at the Grenoble School of Management and Julius Teske at Grenoble, question strongly whether the current acceptance of hybrid vehicle technology particularly in the USA is in any way environmentally sustainable.

The researchers have analyzed the spread of this technology including the non-financial drivers for its adoption. They point out that most manufacturers are rapidly integrating hybrid electric vehicles into their technology portfolio, despite the absence of significant profitability.

They add that the misinformed craze for hybrid vehicles especially in the USA, and increasingly in Japan and Europe, and potentially in China, could represent a red light for more innovative technologies, such as viable fuel-cell cars that can use sustainably sourced fuels, such as hydrogen. They concur with earlier studies that suggest that hydrogen fuel cells will not be marketable in high volumes before at least 2025. This could, however, be too late for some models of climate change and emissions reduction. They also point out that even fuel cell technology has its drawbacks and much of the marketing surrounding its potential has emerged only from the hydrogen lobby itself.

"There is a general convergence of strategies towards promoting hybrid vehicles as the mid-term solution to very low-emission and high-mileage vehicles," the researchers assert, "this is largely due to Toyotas strategy of learning the technology, while building up its own quasi-standard, thanks to its high-quality and reliability reputation and its high market share on the North American market." They add that, "Such a convergence is based more on customer perception triggered by very clever marketing and communication campaigns than on pure rationale scientific arguments and may result in the need for any manufacturer operating in the USA to have a hybrid electric vehicle in its model range in order to survive."

Moreover, political pressures also play a significant part. The three major US manufacturers - GM, Ford, and Chrysler - recently urged President Bush to financially and politically support a national technological solution for hybrids; this was independent of the currently dominant solutions initiated by Toyota. The researchers concede that, "The quest for low emission, clean, and high-mileage vehicles is on its way and should be at the top of the manufacturers' agenda," they say. However, they suggest that the technology, marketing, and public perception leads to one overriding problem: Is a hybrid strategy sustainable in the long run? Chanaron and Teske think not.

The complexity and high cost of the hybrid technology is also playing against itself," they say, "There is a huge strategic dilemma for the key players of the automotive industry where a mistake in technology decision-making might turn even a big player into a take-over candidate. The next five years will provide industry observers with more accurate trends and success or failure factors."


'/>"/>

Contact: Albert Ang
a.ang@inderscience.com
Inderscience Publishers
Source:Eurekalert

Related medicine news :

1. 9/11 Exposure Linked to Behavior Trouble in Kids
2. Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
3. Urinary dysfunction troubles men who undergo prostate removal
4. Caffeine Could Spell Trouble for Diabetics
5. New Colon Cancer Test Might Spot Trouble Earlier
6. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble
7. Holiday Travel, Bad Eating Habits a Recipe for Stomach Trouble
8. Abdominal Fat Tied to High Risk for Coronary Trouble
9. Vioxx Ban Tied to Rise in Serious GI Trouble
10. Early Weight Gain Can Mean Heart Trouble Later in Life
11. Trouble deciding?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: